BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 18034617)

  • 1. Literature-based compound profiling: application to toxicogenomics.
    Frijters R; Verhoeven S; Alkema W; van Schaik R; Polman J
    Pharmacogenomics; 2007 Nov; 8(11):1521-34. PubMed ID: 18034617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the expression profiles induced by genotoxic and nongenotoxic carcinogens in rat liver.
    Ellinger-Ziegelbauer H; Stuart B; Wahle B; Bomann W; Ahr HJ
    Mutat Res; 2005 Aug; 575(1-2):61-84. PubMed ID: 15890375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene ontology mapping as an unbiased method for identifying molecular pathways and processes affected by toxicant exposure: application to acute effects caused by the rodent non-genotoxic carcinogen diethylhexylphthalate.
    Currie RA; Bombail V; Oliver JD; Moore DJ; Lim FL; Gwilliam V; Kimber I; Chipman K; Moggs JG; Orphanides G
    Toxicol Sci; 2005 Aug; 86(2):453-69. PubMed ID: 15901911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiles in rat liver slices exposed to hepatocarcinogenic enzyme inducers, peroxisome proliferators, and 17alpha-ethinylestradiol.
    Werle-Schneider G; Wölfelschneider A; von Brevern MC; Scheel J; Storck T; Müller D; Glöckner R; Bartsch H; Bartelmann M
    Int J Toxicol; 2006; 25(5):379-95. PubMed ID: 16940010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicogenomics and cancer risk assessment: a framework for key event analysis and dose-response assessment for nongenotoxic carcinogens.
    Bercu JP; Jolly RA; Flagella KM; Baker TK; Romero P; Stevens JL
    Regul Toxicol Pharmacol; 2010 Dec; 58(3):369-81. PubMed ID: 20801182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of hepatocarcinogen-induced gene expression profiles in conventional primary rat hepatocytes with in vivo rat liver.
    Doktorova TY; Ellinger-Ziegelbauer H; Vinken M; Vanhaecke T; van Delft J; Kleinjans J; Ahr HJ; Rogiers V
    Arch Toxicol; 2012 Sep; 86(9):1399-411. PubMed ID: 22484513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of specific mRNA signatures as fingerprints for carcinogenesis in mice induced by genotoxic and nongenotoxic hepatocarcinogens.
    Kossler N; Matheis KA; Ostenfeldt N; Bach Toft D; Dhalluin S; Deschl U; Kalkuhl A
    Toxicol Sci; 2015 Feb; 143(2):277-95. PubMed ID: 25410580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inverse gene expression patterns for macrophage activating hepatotoxicants and peroxisome proliferators in rat liver.
    McMillian M; Nie AY; Parker JB; Leone A; Kemmerer M; Bryant S; Herlich J; Yieh L; Bittner A; Liu X; Wan J; Johnson MD
    Biochem Pharmacol; 2004 Jun; 67(11):2141-65. PubMed ID: 15135310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristic expression profiles induced by genotoxic carcinogens in rat liver.
    Ellinger-Ziegelbauer H; Stuart B; Wahle B; Bomann W; Ahr HJ
    Toxicol Sci; 2004 Jan; 77(1):19-34. PubMed ID: 14600272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MILANO--custom annotation of microarray results using automatic literature searches.
    Rubinstein R; Simon I
    BMC Bioinformatics; 2005 Jan; 6():12. PubMed ID: 15661078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction model of potential hepatocarcinogenicity of rat hepatocarcinogens using a large-scale toxicogenomics database.
    Uehara T; Minowa Y; Morikawa Y; Kondo C; Maruyama T; Kato I; Nakatsu N; Igarashi Y; Ono A; Hayashi H; Mitsumori K; Yamada H; Ohno Y; Urushidani T
    Toxicol Appl Pharmacol; 2011 Sep; 255(3):297-306. PubMed ID: 21784091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of predictive models for nongenotoxic hepatocarcinogenicity using both toxicogenomics and quantitative structure-activity relationships.
    Liu Z; Kelly R; Fang H; Ding D; Tong W
    Chem Res Toxicol; 2011 Jul; 24(7):1062-70. PubMed ID: 21627106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of toxicogenomics to genetic toxicology risk assessment.
    Thybaud V; Le Fevre AC; Boitier E
    Environ Mol Mutagen; 2007 Jun; 48(5):369-79. PubMed ID: 17567850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive toxicogenomics approaches reveal underlying molecular mechanisms of nongenotoxic carcinogenicity.
    Nie AY; McMillian M; Parker JB; Leone A; Bryant S; Yieh L; Bittner A; Nelson J; Carmen A; Wan J; Lord PG
    Mol Carcinog; 2006 Dec; 45(12):914-33. PubMed ID: 16921489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collaborative study on fifteen compounds in the rat-liver Comet assay integrated into 2- and 4-week repeat-dose studies.
    Rothfuss A; O'Donovan M; De Boeck M; Brault D; Czich A; Custer L; Hamada S; Plappert-Helbig U; Hayashi M; Howe J; Kraynak AR; van der Leede BJ; Nakajima M; Priestley C; Thybaud V; Saigo K; Sawant S; Shi J; Storer R; Struwe M; Vock E; Galloway S
    Mutat Res; 2010 Sep; 702(1):40-69. PubMed ID: 20656055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo murine hepatic microRNA and mRNA expression signatures predicting the (non-)genotoxic carcinogenic potential of chemicals.
    Melis JP; Derks KW; Pronk TE; Wackers P; Schaap MM; Zwart E; van Ijcken WF; Jonker MJ; Breit TM; Pothof J; van Steeg H; Luijten M
    Arch Toxicol; 2014 Apr; 88(4):1023-34. PubMed ID: 24390151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of an approach for ab initio estimation of compound-induced liver injury based on global gene transcriptional profiles.
    Dai X; He YD; Dai H; Lum PY; Roberts CJ; Waring JF; Ulrich RG
    Genome Inform; 2006; 17(2):77-88. PubMed ID: 17503381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of toxicogenomics approaches for assessing the risk of nongenotoxic carcinogenicity in rat liver.
    Eichner J; Wrzodek C; Römer M; Ellinger-Ziegelbauer H; Zell A
    PLoS One; 2014; 9(5):e97678. PubMed ID: 24828355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene set-level network analysis using a toxicogenomics database.
    Kiyosawa N; Manabe S; Sanbuissho A; Yamoto T
    Genomics; 2010 Jul; 96(1):39-49. PubMed ID: 20363313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissecting modes of action of non-genotoxic carcinogens in primary mouse hepatocytes.
    Schaap MM; Zwart EP; Wackers PF; Huijskens I; van de Water B; Breit TM; van Steeg H; Jonker MJ; Luijten M
    Arch Toxicol; 2012 Nov; 86(11):1717-27. PubMed ID: 22710402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.